Latham Group, Inc. (SWIM) Financial Statements
Latham Group, Inc. (SWIM) reported trailing twelve-month revenue of $576.6M (up 10.5% year on year) and net income of $5.3M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $49.0M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SWIMLatham Group, Inc.Follow SWIM — free
—
Price chart with a free account
- Market cap
- 781.8M
- P/E TTM
- 132.9
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Revenue | 630.5 | 695.7 | 566.5 | 508.5 | 545.9 | 576.6 | |
| Gross profit | 204.2 | 216.5 | 152.9 | 153.7 | 182.1 | 192.5 | |
| Operating income | -36.2 | 30.0 | 16.1 | 18.3 | 30.6 | 29.3 | |
| Pre-tax income | -53.5 | 13.7 | -10.1 | -8.7 | 13.5 | 9.9 | |
| Income tax | 8.8 | 19.4 | -7.7 | 9.1 | 2.4 | 4.6 | |
| Net income | -62.3 | -5.7 | -2.4 | -17.9 | 11.1 | 5.3 | |
| Diluted EPS ($) | -0.56 | -0.05 | -0.02 | -0.15 | 0.09 | 0.05 | |
| Diluted shares (mn) | 110.6 | 113.2 | 112.9 | 115.4 | 119.8 | — |
USD millions · SEC XBRL
Latham Group, Inc. — questions
- What is Latham Group, Inc.'s revenue?
- $576.6M over the twelve months to 2026-06-30, up 10.5% year on year, from its 10-Q and 10-K filings.
- What is Latham Group, Inc.'s net income?
- $5.3M over the twelve months to 2026-06-30.
- What is Latham Group, Inc.'s free cash flow?
- $49.0M over the twelve months to 2026-06-30.
- What are Latham Group, Inc.'s diluted earnings per share?
- $0.05 over the twelve months to 2026-06-30.
Every figure on this page comes from Latham Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.